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Introduction 41
Malaria remains a scourge of the developing world, causing nearly 500,000 deaths per year, 42 with the overwhelming majority due to infection by the intracellular parasite Plasmodium falciparum 43
(1). While the life cycle of P. falciparum includes replication in both the liver and blood, symptomatic 44 human disease is caused by infection of red blood cells (RBCs) (2). Upon infection of a host RBC, the 45 parasite executes a dramatic protein export program, sending hundreds of parasite proteins through the 46 secretory system and across the surrounding vacuole (parasitophorous vacuole, PV), into the host 47 cytosol (3, 4). These exported effectors drastically remodel the host cell, setting up new solute 48 permeability pathways, modifying the RBC shape and rigidity, and reconstituting trafficking machinery in 49 the RBC cytosol to send parasite-encoded adhesins to the RBC surface (3, 4). These adhesins mediate 50 binding of infected RBCs to vascular endothelia allowing parasites to avoid splenic clearance. Adherent 51 parasites in the brain can cause vascular blockage leading to death in severe cases (2) . 52
Due to the central role of protein export in the survival and virulence of P. falciparum, there has 53 been considerable interest in this process as a source of drug targets. One target of interest has been 54 the parasite aspartic protease plasmepsin V (PMV). PMV processes exported proteins in the parasite ER 55 by cleaving them co-translationally in a variant signal recognition particle complex (5) at a conserved 56 amino acid export motif termed the Plasmodium export element (PEXEL) (6-8). PMV is highly specific for 57 RxL in the PEXEL and cleaves after the leucine (9-12). PEXEL processing is a critical step in protein 58 export, as mutations in PEXEL that block PMV processing also block protein export (9, 10). Furthermore, 59 processing of PEXEL proteins is likely an essential function in the parasite, as PMV knockouts have thus 60 far been unobtainable in the rodent malaria parasite P. berghei (6, 7, 13), a catalytic aspartate mutant of 61 PMV acts as a dominant negative, reducing growth of cultured P. falciparum (7) , and a conditional PMV 62 knockout in P. falciparum is lethal (14) . 63
In recent years, a number of tools have been used to study PMV, including peptidomimetic 64 inhibitors that block its function in vitro and appear to be on-target and lethal to parasites in culture 65 (15-17), as well as a crystal structure of the P. vivax PMV (18). However, study of PMV function has been 66 hindered due to an inability of previous knockdown methods to yield a phenotype in RBC culture. The 67 most robust knockdown described to date used the glmS ribozyme system to reduce PMV levels 10-fold. 68
However, this had no measurable effect on parasite growth (15). Here, we sought to apply the recently 69 described TetR-DOZI aptamer system for stringent and tunable regulation of PMV (19). This system has 70 been shown to deplete a reporter gene 45 to 70-fold when aptamers are installed in both the 5' and 3' 71 untranslated regions (UTRs) of the target gene (19). However, cloning such a construct in traditional 72 plasmid systems requires the assembly and maintenance of large circular plasmids that are prone to 73 deletions and vector rearrangements during propagation in E. coli (20). To overcome this technical 74 challenge, we assembled a number of tools for genetic manipulation onto a previously described linear 75 vector. Using this new vector system, we achieved substantially greater depletion of PMV than was 76 previously described. We found that depletion of PMV was lethal to parasites, validating PMV as an 77 essential protein in RBC culture. By tuning the degree of knockdown, we showed that PMV is maintained 78 at substantial excess during RBC infection and must be suppressed to nearly undetectable levels to 79 affect parasite growth. Finally, we found that PMV-depleted parasites die immediately after invasion in 80 a manner distinct from that of disruptions of other protein export machinery, suggesting PMV may have 81 additional roles beyond those previously described. 82 5 84 85
Results 86
Constructions of a linear vector for aptamer knockdowns. To overcome the challenges 87 associated with maintaining P. falciparum genomic material in circular plasmids, we utilized the pJAZZ 88 linear vector system (20) as a chassis for DNA assembly operations. This system has previously been 89 used to manipulate large [A+T]-rich genomic fragments, including those derived from the rodent malaria 90 parasite, P. berghei (20, 21). We constructed a plasmid (pSN054) to allow facile cloning, endogenous 91 tagging, robust regulation of expression and/or inducible knockout of P. falciparum genes ( Fig. 1A, Fig . 92 S1). pSN054 has the following features: a single 5' aptamer, a 10x array of 3' aptamers, a fixed 93 regulatory protein (TetR-DOZI repressor complex)(19), a parasitemia tracking component (Renilla 94 luciferase), a drug selection marker, a cassette for generation of sgRNA for CRISPR/Cas9 genome editing, 95 modular cloning sites for inserting left homologous regions (LHRs) and right homologous regions (RHRs) 96 for homologous repair, modularized affinity tags for tagging genes of interest at the N-terminus or C-97 terminus and loxP sites for gene excision if needed ( Fig. 1) . 98
To utilize pSN054 for genome editing, a gene of interest must be recodonized to replace the 99 current gene, preventing aberrant homologous repair from truncating the construct. To facilitate repair, 100 400-600bp of left and right homologous regions (LHR and RHR), corresponding to 5'UTR and 3'UTR of a 101 gene, are cloned into the FseI and I-SceI restriction sites respectively ( Fig. S1 ). This intermediate vector 102
can be used to create gene knockouts since it does not possess the coding sequence of the gene of 103 interest. A subsequent Gibson assembly is then performed to insert the coding sequence of the gene. 104
There are several choices for this step depending on the tag one desires and whether this tag is N or C-105 terminal. pSN054 contains the 2A skip peptide (23) such that cloning into the AsiSI site produces a 106 protein with no tag on the N-terminus. If an N-or C-terminal tag is desired, the relevant cloning site is 6 used for gene insertion (Fig. 1A ). This donor plasmid can be adapted for use with the T7-RNAP pieces of the 5'UTR and 3'UTR into FseI and I-SceI respectively, as well as a recoded version of the PMV 112 coding sequence into plasmid cut with AsiSI and BsiWI (Fig. 1B ). This plasmid enables us to 113 simultaneously tag PMV with a C-terminal FLAG tag and regulate expression with the TetR-DOZI system 114 ( Fig. 1B) . The construct was transfected into NF54 (26), and parasites selected and cloned. Incorporation 115 of the construct into the genome was verified by Southern blot ( Fig. 2A ). Expression of a FLAG-tagged 116 protein of the expected size was verified by western blot (Fig. 2B ). Similarly, a western blot with anti-117 PMV verified that modification of this locus did not substantially change PMV expression levels of the 118 edited line relative to the parent (Fig. 2C ). 119
We then utilized the TetR-DOZI aptamer system to post-transcriptionally deplete PMV. Knock 120 down was initiated by washing out anhydrotetracycline (aTc) from young ring-stage parasites in RBC 121 culture. In the absence of aTc, PMV levels were depleted about 50-fold ( Fig. 2D ) and parasite growth 122 was arrested after 96 hours ( Fig. 2E ). This confirms that PMV is essential for intraerythrocytic growth 123 and showcases the ability of the TetR-DOZI aptamer system to drive more substantial depletion of 124 proteins than previously possible. 125 PMV is maintained in substantial excess during infection. We next sought to utilize the tunability of the 126 TetR system to determine the amount of PMV required for parasite survival. To this end, we titrated aTc 127 levels and followed parasite growth by flow cytometry (Fig. 3A ). Parasites maintained in 3 nM aTc or 128 above grew normally. Parasites maintained in DMSO or 1 nM aTc arrested by 96h, while parasites 129 maintained in 2 nM aTc survived an additional cycle before arresting at 120h (Fig. 3A) . Given this, we 130 sought to determine the amount of PMV depletion necessary to affect parasite growth. We 7 synchronized parasites and washed out aTc from cultures containing predominantly young ring-stage 132 parasites, then harvested samples for western blot at 72h following washout to compare the PMV levels 133 in parasites that would go on to survive another cycle (2 nM aTc) to those that would arrest in the next 134 24h (1 nM aTc). Over three independent experiments, we found that 8% of wildtype PMV (2 nM aTc) 135 was sufficient to support another cycle of growth, while 3% (1 nM aTc) was insufficient and led to death 136 upon reinvasion ( Fig. 3B, C ). This suggests that PMV is maintained in enormous functional excess in 137 parasite culture. 138 PMV depleted parasites arrest early in life cycle. Given the canonical role of PMV in parasite protein 139 export, we expected PMV depletion to phenocopy disruption of other critical export machinery such as 140 components of the Plasmodium translocon for exported proteins (PTEX) which mediates translocation of 141 effectors across the PV membrane (3, 27, 28). PTEX components Hsp101, PTEX150 and EXP2 are all 142 essential in parasite culture, and previously described depletion of any of these caused parasite arrest 143 during the early trophozoite stage (29-31). Therefore, we were surprised to find that PMV depletion 144 caused growth arrest very early in the intraerythrocytic development cycle, shortly after invasion ( Fig.  145 4A). Arrested parasites were further investigated by transmission electron microscopy and were found 146 to have gross structural abnormalities ( Fig. 4B ). PMV-depleted parasites generally showed more electron 147 density throughout the parasite cytosol, failure to expand much beyond the size of merozoites, and 148 large unidentified vacuolar structures within the parasite. In contrast, when parasites were fixed as 149 schizonts from the preceding cycle, there was no obvious morphological defect ( Fig. 4C ). This suggests 150 that PMV plays some critical role(s) in parasites immediately after invasion, distinct from its canonical 151 protein export role. 152 depletion leads to parasite growth arrest early after invasion, we sought to recapitulate the previously 156 described early trophozoite death as well as our early post-invasion death with the peptidomimetic PMV 157 inhibitor WEHI-842 (16, 18). We treated synchronized ring-stage parasites or schizonts with 5 μM WEHI-158 842 for an 8-hour window, then monitored parasites by thin smear. We found that ring-stage parasites 159 treated with WEHI-842 arrested as early-trophozoites as previously described (Fig. 5A ) However, 160 parasites treated with WEHI-842 beginning in schizogony arrested immediately after invasion, as was 161 seen in our genetic PMV depletion line ( Fig. 5B ). Taken together, our data suggest that parasites are 162 sensitive to PMV inhibition during two points in the life cycle. The first is immediately after invasion. The 163 second is in early trophozoites and is phenocopied by PTEX disruptions. 164
165
Discussion 166
We report the first regulatable knockdown that lowers PMV levels enough to provide a lethal 167 phenotype. This work overcomes the technical limitations of past knockdown systems by utilizing the 168
TetR system with aptamers on both the 5' and 3' end of the gene of interest. This manipulation was 169 greatly facilitated by the plasmid described here, pSN054, which enables a suite of previously described 170 genetic tools to be utilized with relative ease for gene editing to achieve protein tagging, regulation of 171 gene expression, parasite growth monitoring and inducible knockout as required. 172
An unexpected result is that PMV depletion does not phenocopy the disruption of PTEX 173 components (29-31). The fact that the post-invasion death phenotype described here is not seen in 174 disruption of other export machinery suggests that PMV has some role independent of protein export 175 that is essential for parasite survival in RBCs. A reasonable hypothesis is that this role could be the 176 cleavage of a critical substrate early in the life cycle to allow it to perform an essential activity. In this 177 case, the substrate would likely be acting within the parasite or within its vacuole, since disruption of 9 but only arrested growth in early trophozoites (29). The identity of this substrate is an interesting 180 avenue for future research. Alternatively, early death could be a non-specific result of PMV deficiency, 181 such as a buildup of uncleaved PEXEL proteins in the ER. Consistent with this, treatment with the 182 canonical ER-stress inducer DTT arrested growth in P. falciparum with similar morphology by Giemsa 183 stain to that caused by PMV depletion described here (32). 184
One encouraging note for the development of PMV inhibitors as antimalarials is our finding that 185 PMV inhibition can lead to parasite death at two distinct points within intraerythrocytic development. 186
Knockdown of PTEX components seem to cause growth arrest only at one point in blood-stage parasites 187 (29-31). Specifically, when Hsp101 or EXP2 protein levels were reduced to barely detectable levels in 188 late-stage parasites, the parasites proceeded to invade and develop normally before arresting at the 189 early trophozoite stage (30-31). Due to this, drugs inhibiting the function of PTEX components may take 190 up to a full intraerythrocytic cycle (48 hours) to reach the point in the cycle where growth arrest occurs. 191
In contrast, PMV inhibitors may be able to arrest growth more quickly by acting upon intraerythrocytic 192 parasites at more than one point in the life cycle. This may bring a potential PMV inhibitor in line with 193 recommendations that an ideal antimalarial act within 24 hours (33). However, this beneficial 194 characteristic is counterbalanced by the important insight from our study that PMV must be suppressed 195 to barely detectable levels to affect parasite growth. This may make PMV a challenging target for drug 196 development as concentrations of inhibitors far beyond the IC 50 calculated with purified enzyme may be 197 required to cause parasite death. Peptidomimetic inhibitors of PMV that have been developed are 198 generally greater than 100-fold less potent in culture than on isolated enzyme (15, 17, 18). It has been 199 presumed that potency against parasites is limited by cellular permeability. Our functional genetics data 200 would suggest that an additional, and possibly major, component of the potency drop-off is the need to 201 inhibit nearly all the cellular enzyme to kill parasites. We usually measure enzyme inhibition in terms of 202 an IC 50 value, but in this case an IC 99 might be more relevant to whole parasite killing. 203
Taken together, our study provides further data on the proposed antimalarial drug target 204 plasmepsin V. Future work is needed to determine if PMV is maintained at excessive levels in vivo as it is 205 in vitro, and to elucidate the cause of growth arrest after invasion in PMV-depleted parasites. Transfectants were maintained in 0.5 μM anhydrotetracycline (aTc; Cayman Chemical) and were 233 selected beginning 24 hours post transfection with Blasticidin S (2.5 μg/mL; Fisher). Parasites were 234 obtained from several independent transfections and clones obtained by limiting dilution. 235
Validation of PMV APT line. Proper integration of our construct was verified by Southern Blot as in (24). 236
For a probe, the right homologous region was amplified from NF54 genomic DNA using primers 237 described above. 238
To verify tagging of protein, schizonts of NF54 and PMV APT were first synchronized by purifying 239 on magnetic columns (Miltenyi Biotech) then allowed to invade fresh uninfected RBCs for 3 hours before 240 remaining schizonts were cleared with 5% sorbitol. Parasites were then allowed to progress for 40h, 241 then RBCs lysed with cold PBS + 0.035% saponin. Lysates were centrifuged to pellet parasites and 242 remove excess hemoglobin, then parasites were lysed in RIPA (50mM Tris, pH 7.4; 150mM NaCl; 0.1% 243 SDS; 1% Triton X-100; 0.5% DOC) plus HALT-Protease Inhibitor Cocktail, EDTA-free (Thermo Fisher). 244
Lysates were centrifuged at high speed to pellet and remove hemozoin. Figure S3 ). Blots were quantitated using Licor Image Studio. The experiment was performed 266 three times and the mean for those three experiments is plotted with error bars representing the 267 standard error of the mean. 268 WEHI-842 treatment. Parasites were synchronized to within 3 hours as above (see Validation of PMV APT 269 line above, paragraph 2). Then either 5 μM WEHI-842, or an equal volume of DMSO was added to late 270 rings (15h after invasion initiated; parasites 12-15h old), or late trophozoites (44 hours after invasion 271 initiated; parasites 41-44h old). Parasites were incubated with drug or DMSO for 8h, then assessed by 272 thin smear. The experiment was performed twice, with similar results in each. Representative images 273 from one experiment are shown. 274 (MilliporeSigma). Images were taken using a Zeiss Axio Observer.D1 at the Washington University 276 Molecular Microbiology Imaging Facility. For transmission electron microscopy, infected RBCs were fixed 277 in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM sodium 278 cacodylate buffer, pH 7.2 for 1 hr at room temperature. Samples were washed in sodium cacodylate 279 buffer at room temperature and postfixed in 1% osmium tetroxide (Polysciences Inc.) for 1 hr. Samples 280 were then rinsed extensively in dH 2 0 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella  281 Inc., Redding, CA) for 1 hr. Following several rinses in dH 2 0, samples were dehydrated in a graded series 282 of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). Sections of 95 nm were cut with a Leica 283
Ultracut UCT ultramicrotome (Leica Microsystems Inc., Bannockburn, IL), stained with uranyl acetate 284 and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA Inc., 285 Peabody, MA) equipped with an AMT 8-megapixel digital camera and AMT Image Capture Engine V602 286 software (Advanced Microscopy Techniques, Woburn, MA). 287 Database links. Sequences for genes used in this study were obtained from PlasmoDB (Release 38) using 288 the following gene IDs: plasmepsin V (PF3D7_1323500), HAD1 (PF3D7_1033400). Also discussed were 289 Hsp101 (PF3D7_1116800), Exp2 (PF3D7_1471100), and PTEX150 (PF3D7_1436300). 290
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